CONCORDE -a phase Ib platform study of novel agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)
Authors
Horne, AshleyBrown, S.
Butterworth, K.
Chalmers, A.
Collinson, F.
Dive, Caroline
Faivre-FInn, Corinne
Forster, M.
Franks, K.
Gilbert, A.
Hallam, M.
Hanna, G.
Harrow, S.
Hartley, J.
Hiley, C.
Jones, R.
Katona, E.
Kendall, J.
Krebs, Matthew G
Mallison, G.
Oughton, J. B.
Phillip, R.
Rothwell, Dominic G
Sebag Montefiore, D.
Shaw, P.
Walls, G.
Walker, F.
Young, R.
Greystoke, A.
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Horne A, Brown S, Butterworth K, Chalmers A, Collinson F, Dive C, et al. CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 2022 Sep;17(9):S267-S8. PubMed PMID: WOS:000858678100440.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2022.07.454Additional Links
https://dx.doi.org/10.1016/j.jtho.2022.07.454Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2022.07.454